CytoGenix Inc. has executed the first license for the use of its proprietary single stranded DNA intracellular expression vector (TroVec) to PharmaGenix LLC., owned jointly by CYGX and PCCA (Professional Compounding Centers of America Inc). PharmaGenix is the first company to combine the traditional science and skills of compounding pharmacists with those molecular biologists and Read more about CytoGenix Licenses Trovec Antisense Delivery System To PharmaGenix[…]